A DEA Form 357 import permit is mandatory before shipment, and the importer must hold a valid DEA Schedule II registration. FDA requires that the substance originate from a registered foreign drug establishment. Customs entry must include the DEA permit number, and the shipment is subject to port-of-entry examination. Any discrepancy between the permit quantity and the actual shipment can result in seizure and criminal referral.

Legitimate commercial imports under 2934920000 are accompanied by a DEA import permit, commercial invoice identifying the specific INN compound, and FDA drug establishment registration documentation. CBP coordinates with DEA and FDA on targeting; shipments lacking these credentials or arriving via non-commercial channels are flagged for intensive examination. The single-line structure of this heading means all fentanyl-class thiazole derivatives share the same tariff treatment, so chemical identity documentation is critical for both compliance and enforcement purposes.